Loading
Get Assure Program Enrollment Form For Rexulti Brexpiprazole
How it works
-
Open form follow the instructions
-
Easily sign the form with your finger
-
Send filled & signed form or save
How to fill out the ASSURE Program Enrollment Form For REXULTI Brexpiprazole online
Filling out the ASSURE Program Enrollment Form for REXULTI (brexpiprazole) online is a straightforward process that allows for efficient enrollment in the program. This guide provides clear, step-by-step instructions to assist you in completing each necessary section of the form accurately and effectively.
- Begin by locating the 'Get Form' button to access the ASSURE Program Enrollment Form. Click this button to retrieve the form and open it for editing.
- In the first section labeled 'Prescriber Information,' fill out all applicable fields. This includes the prescriber’s name, license number, state of licensure, facility address, and contact information. If available, provide an alternate contact as well, although this is optional.
- Proceed to fill in the 'Patient Information' section. Enter the patient's first and last name, middle initial, date of birth, gender, and contact details. Additionally, ensure the Social Security Number is included, especially for the Patient Assistance Program.
- Next, in the 'Prescription Information & Prescriber Authorization' section, input the primary diagnosis code, prescribed dosage, quantity, and any refills as necessary. Remember that the prescriber’s signature is mandatory even if a prescription copy is attached.
- Complete the 'Patient Insurance Information' section by either submitting copies of the insurance cards or entering the insurance details directly into the provided fields. If the patient lacks insurance, indicate this accordingly.
- Review the 'Patient Authorization' section, which is optional. By signing this section, the patient consents to the sharing of their protected health information necessary for program participation.
- Once all sections are completed, ensure that all changes are saved. You may then choose to download, print, or share the form as needed.
Complete the ASSURE Program Enrollment Form online today to ensure timely processing and support.
The FDA has accepted a supplemental new drug application (sNDA) for Rexulti (brexpiprazole) for use in the treatment of agitation associated with Alzheimer's dementia (AAD). The FDA has assigned the application priority review and a Prescription Drug User Fee Act (PDUFA) target action date of May 10, 2023.
Industry-leading security and compliance
US Legal Forms protects your data by complying with industry-specific security standards.
-
In businnes since 199725+ years providing professional legal documents.
-
Accredited businessGuarantees that a business meets BBB accreditation standards in the US and Canada.
-
Secured by BraintreeValidated Level 1 PCI DSS compliant payment gateway that accepts most major credit and debit card brands from across the globe.